Intelligence · Clinical Pipeline
Novartis India Pipeline
All ClinicalTrials.gov programs at Novartis India — phase, modality, and trial IDs.
- Programs
- 341
Quick answer
Novartis India has 341 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Zoledronic Acid
Novartis Pharmaceuticals
Paget's Disease of the Bone
1 trial -
brinzolamide 1%/brimonidine 0.2% fixed combination
Novartis Pharmaceuticals
Glaucoma
1 trial -
carbidopa, levodopa, entacapone
Novartis Pharmaceuticals
Parkinson's Disease
1 trial -
dabrafenib
Novartis Pharmaceuticals
Melanoma
1 trial -
Blood draw for Lp(a)
Novartis Pharmaceuticals
Cardiovascular Disease and Lipoprotein(a)
1 trial
Frequently asked questions
How many pipeline programs does Novartis India have?
341 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs